Arcturus Therapeutics Holdings Current Deferred Revenue (Quarterly) Insights

Arcturus Therapeutics Holdings, Inc. (ARCT)

6.185 +0.02 (+0.41%) USD | NASDAQ | Dec 30, 16:00

6.03 -0.16 (-2.51%) After-Hours: 18:07

View Current Deferred Revenue (Quarterly) for ARCT.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Current Deferred Revenue (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Current Deferred Revenue (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Current Deferred Revenue (Quarterly) Benchmarks

Start Trial

Inovio Pharmaceuticals, Inc.	--
Perspective Therapeutics, Inc.	Upgrade
Novavax, Inc.	Upgrade
Sangamo Therapeutics, Inc.	Upgrade
Myomo, Inc.	Upgrade